Welcome to the Urea Cycle Disorders Consortium!
The UCDC exists to bring together physicians and patients for the sake of Urea Cycle Disorders research.
We Need Your Help
The future of urea cycle disorders research begins here. Every active role a patient takes may possibly play a part in discovering new groundbreaking research and finding new treatments.
Research cannot move forward with out your help.
City Biz List: Children's National Research Team Awarded $2 Million for Urea Cycle Disorders Study. A research team at Children's National has been approved for a $2.1 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to evaluate treatment options and impacts of care delivery for patients with Urea cycle disorders (UCD), rare genetic diseases predominately of childhood. Mendel Tuchman, MD, Chief Research Officer, Children's National and Scientific Director, Children's Research Institute will lead the study along with Mary Elizabeth McGehee Joyce Professor of Pediatrics, the George Washington University School of Medicine.
City Biz List: Mark L. Batshaw, MD, Receives C. Anderson Aldrich Award from American Academy of Pediatrics. Mark L. Batshaw, MD, Executive Vice President, Physician-In-Chief, and Chief Academic Officer, received the C. Anderson Aldrich award, during the AAP Section on Developmental and Behavioral Pediatrics in Washington, DC, on October 24 at the AAP National Conference and Exhibition.
Registries for Rare Diseases: Involve the Patient. As part of an ongoing editorial collaboration with Medscape Rare Diseases, Marshall Summar, MD, Center for Neuroscience and Behavioral Medicine, speaks about the importance of involving patients in the field through patient registries which help physicians and researchers begin to understand rare disease and develop better therapies.
Press Release: The Urea Cycle Disorders Consortium is awarded $6.25 million over the next 5 years in the latest round of funding from the National Institutes of Health (NIH) to perform clinical research and develop new treatments for patients with urea cycle disorders (UCD).
Mark L. Batshaw, MD, Physician-in-Chief and Chief Academic Officer for Children's National, Says Drug Development for Rare Diseases in Children at a 'Tipping Point.' More clinical trials, increased patient advocacy, and collective work in a multi-disciplinary consortia of healthcare organizations, are becoming increasingly important "to move forward" rare disease research for children, says Mark L. Batshaw, MD, Physician-in-Chief and Chief Academic Officer for Children's National Health System.
4th International Symposium on Urea Cycle Disorders: Catalyzing New Therapeutic Approaches
ABC News Story: April 26, 2012 - ABC News featured a story on a young man with ASA and chronically high blood pressure. Dr. Brendan Lee’s (Baylor College of Medicine) ASA and nitric oxide research led to a new approach to treat his condition. http://abcnews.go.com/Health/boy-toxic-buildup-breakthrough-treatment/story?id=16213994.
Baylor College of Medicine News: November 13, 2011 - 'Moonlighting' enzyme unravels arginine paradox. http://www.bcm.edu/news/item.cfm?newsID=4725
Washington Post: November 25, 2010 – Dr. Uta Lichter-Konecki diagnoses girl with UCD. http://www.washingtonpost.com/wp-dyn/content/article/2010/11/24/AR2010112406714.html
Washington Post Featured Story: Saving a girl from her own body's poisons Read More >Good Morning America: May 7, 2006 - Mark Batshaw, M.D., Principle Investigator for the Urea Cycle Disorders Consortium and member of the NUCDF Medical Advisory Board, was interviewed by Good Morning America for a segment that aired May 7, 2006. The segment profiled the Rare Diseases Clinical Research Centers, sponsored by the National Institutes of Health. The segment focused on our Urea Cycle Disorders Consortium as an example of this pioneering NIH project.
UCDC Web Site en Español! Mira aqui!
The Urea Cycle Disorders Consortium (UCDC) is a part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS). Funding and/or programmatic support for this project has been provided by the National Institute of Child Health and Human Development (NICHD) and the ORDR, NCATS. Read Disclaimer >